ResearchMoz

Browse reports in Healthcare

Displaying 1 to 30 (of 2272 records)
Cough, Cold, Flu and Allergy Remedies - US - April 2014
Apr 2014   |   By - Mintel
Despite increasing sales, the cough, cold, flu, and allergy market is up against several challenges. Most consumers seek to prevent getting sick, lessening the need for remedies to treat their ailments. Additionally, it is difficult to predict the severity of a given cold or flu season. Providing ways to help consumers get the exact product to fit their needs can help to increase brand loyalty.
$3996
Cough, Cold, Flu and Allergy Remedies - UK - April 2014
Apr 2014   |   By - Mintel
In 2013, the cold/flu and allergy relief remedies market benefited from increases in product launch activity and marketing activity. Going forward, brands could look to more specifically target the key young adult demographic, who are the most likely to suffer from cold/flu and allergy-based ailments, as well as encouraging people in general to prepare ahead of both cold/flu and hayfever...
$2835
Research Report on Medical Industry in China 2014 - 2018
Apr 2014   |   By - China Research and Intelligence Co., Ltd. (CRI)
In China, medical institutions refer to licensed (the Practice License of Medical Institutions) hospitals, health centers, clinics and first-aid stations that diagnose and treat diseases. As a public service provider, medical institutions are regulated by National Health and Family Planning Commission of China and other related government departments. Uneven regional distribution of...
$2400
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia
Apr 2014   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Indonesia. It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Indonesia, identifying key trends in the healthcare market and providing insights into the demographic, regulatory,...
$1995
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea
Mar 2014   |   By - GlobalData
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea Summary GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in South Korea. It identifies...
$1995
Understanding Myanmars Regional Healthcare Markets
Mar 2014   |   By - Espicom
Commercial opportunities in Myanmar's healthcare sector are mainly derived from its large unmet medical needs and underinvestment. However, we maintain that significant improvements are required if Myanmar is to realise its ambitious public health insurance scheme. In addition, political uncertainties from the upcoming election in 2015 may also deter investors over the short term....
$935
Understanding South Africas Regional Healthcare Markets
Mar 2014   |   By - Espicom
With a new National Health Insurance system being implemented, what will the effects be on the under-resourced public sector and the expensive private sector? And what changes can be seen at the varied regional and provincial levels? Any assessment of South Africa must consider the potential variations across Eastern Cape, Free State, Gauteng, KwaZulu-Natal, Limpopo, Mpumalanga, North...
$935
Non-public Hospitals Market in Poland 2014 Comparative Analysis by Voivodship and Development Prospects
Mar 2014   |   By - PMR
Examine the structure of Poland’s non-public hospital market in 2014 Report offers break down by voivodship, comparative analysis and prospects for development. Openings of new non-public hospitals and recently transformed facilities have been on the rise in Poland. As a result, businesses with interests in the market are asking a lot of questions, such as: What...
$2660
PharmaPoint: Migraine - US Drug Forecast and Market Analysis to 2023
Mar 2014   |   By - GlobalData
The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of therapies are anticipated to...
$4995
PharmaPoint: Migraine - 5EU Drug Forecast and Market Analysis to 2023
Mar 2014   |   By - GlobalData
The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of therapies are anticipated...
$6995
PharmaPoint: Migraine - Japan Drug Forecast and Market Analysis to 2023
Mar 2014   |   By - GlobalData
The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of therapies are anticipated to...
$4995
PharmaPoint: Migraine - Current and Future Players
Mar 2014   |   By - GlobalData
PharmaPoint: Migraine  Current and Future Players. The report is a vital source of uptodate information with indepth analysis on the companies in the rapidly growing Migraine Market. The report identifies and analyses the key companies shaping and driving the global Migraine market. The report provides insight into the competitive Migraine landscape, including new companies entering the...
$2995
Benign Prostatic Hyperplasia - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
This report provides comprehensive information on the therapeutic development for Benign Prostatic Hyperplasia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the...
$2000
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
This report provides comprehensive information on the therapeutic development for Chronic Kidney Disease (Chronic Renal Failure), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key...
$2000
Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
This report provides comprehensive information on the therapeutic development for Non-Alcoholic Steatohepatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the...
$2000
Kidney Disease - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
This report provides comprehensive information on the therapeutic development for Kidney Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic...
$2000
Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
This report provides comprehensive information on the therapeutic development for Bipolar Disorder (Manic Depression), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved...
$2000
Colitis - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
This report provides comprehensive information on the therapeutic development for Colitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic...
$2000
Hemophilia B - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
This report provides comprehensive information on the therapeutic development for Hemophilia B, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic...
$2000
Uveitis - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
This report provides comprehensive information on the therapeutic development for Uveitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic...
$2000
Renal Anemia - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
This report provides comprehensive information on the therapeutic development for Renal Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic...
$2000
Neutropenia - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
This report provides comprehensive information on the therapeutic development for Neutropenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic...
$2000
Diarrhea - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
This report provides comprehensive information on the therapeutic development for Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic...
$2000
Dyskinesia - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
This report provides comprehensive information on the therapeutic development for Dyskinesia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic...
$2000
Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
This report provides comprehensive information on the therapeutic development for Reflux Esophagitis (Gastroesophageal Reflux Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key...
$2000
Kidney Transplantation - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
This report provides comprehensive information on the therapeutic development for Kidney Transplantation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the...
$2000
Thrombocytopenia - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
Thrombocytopenia - Pipeline Review, H1 2014 Summary Global Markets Directs, Thrombocytopenia - Pipeline Review, H1 2014, provides an overview of the Thrombocytopenias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Thrombocytopenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism...
$2000
Erectile Dysfunction - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
Erectile Dysfunction - Pipeline Review, H1 2014 Summary Global Markets Directs, Erectile Dysfunction - Pipeline Review, H1 2014, provides an overview of the Erectile Dysfunctions therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Erectile Dysfunction, complete with comparative analysis at various stages, therapeutics assessment by drug...
$2000
Actinic (Solar) Keratosis - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
Actinic (Solar) Keratosis - Pipeline Review, H1 2014 Summary Global Markets Directs, Actinic (Solar) Keratosis - Pipeline Review, H1 2014, provides an overview of the Actinic (Solar) Keratosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Actinic (Solar) Keratosis, complete with comparative analysis at various stages, therapeutics...
$2000
Acute Respiratory Distress Syndrome - Pipeline Review, H1 2014
Mar 2014   |   By - Global Markets Direct
Acute Respiratory Distress Syndrome - Pipeline Review, H1 2014 Summary Global Markets Directs, Acute Respiratory Distress Syndrome - Pipeline Review, H1 2014, provides an overview of the Acute Respiratory Distress Syndromes therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acute Respiratory Distress Syndrome, complete with comparative...
$2000
 
Displaying 1 to 30 (of 2272 records)

Healthcare Market Research Reports & Industry Analysis

Health related ailments have drastically increased with age across the globe, and thus, the pressing demand for healthcare has increased too.
Over the years, the healthcare industry has shown significant changes in norms and regulations that are driven by new government incentives and new legislations. Today, this industry accounts for large labor intensive care facilities, advancements in medical technologies, and patient requirements – all of which improves the life expectancy in the society as well as the quality of living.
The healthcare sector encompasses two main industry groups. The first category includes the manufacturing of healthcare equipment and supplies consisting of distributors of healthcare products, operators of healthcare facilities, providers of basic health care services and organizations. However, now-a-days, the second category under this field consists of research and development, production, and marketing of various pharmaceuticals and biotechnology products. 
Many people are attracted to the healthcare industry for its service-oriented and human touch-sensitive aspects. In addition, the preference for home health care over hospital settings has increased among the elderly and the chronically ill population too. Now, it is the market for home healthcare and alternative-medical treatments that is expected to grow at a healthy pace. 
Healthcare sector remains one of the rapidly growing industries of the global economy. It poses endless challenges to the private sector and the policy sector in virtually every country in the world. According to worldwide analysts and their statistics, the global healthcare services market is augmented to reach a figure of $3 trillion by the year 2015. It is sectors like telehealth, home healthcare, and healthcare IT in the market that is expected to grow and fuel the market expansion with their developments. 
ResearchMoz is continually in the efforts of providing a continuous flow of information and in-depth market analysis in the form of intelligent research reports that cover this particular healthcare market sector. Our years of proven methodologies, market forecasts, and evaluation of the Healthcare market sector helps you understand the gravity of this industry and grow your business, shaping the future markets for therapeutics to serve in the fight against diabetes, cancer and many other syndromes in the right form. 

Healthcare

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData